Discussion Starter · #1 ·
Probably very good news.
|Scientists have created a gene profiling test that may someday help reveal which people with early lung cancer are likely to suffer a relapse and would benefit most from chemotherapy.|
Separately, other researchers found that several new tumor profiling tests for breast cancer, including two already in general use, are similar in accuracy and should allow many women to avoid unnecessary chemo.
The lung cancer one needs far more testing, but is "breakthrough research" building on years of work to develop personalized cancer treatments, said Dr. Len Lichtenfeld, deputy chief medical officer of the American Cancer Society.